Clinical outcome and molecular characterisation of chemorefractory metastatic colorectal cancer patients with long-term efficacy of regorafenib treatment

BACKGROUND: To investigate the potential predictors of response to regorafenib, in chemorefractory metastatic colorectal cancer (mCRC) patients with long-term efficacy from regorafenib treatment. METHODS: Retrospective, single institution analysis of patients with chemorefractory mCRC treated with r...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:ESMO Open
Auteurs principaux: Martinelli, Erika, Sforza, Vincenzo, Cardone, Claudia, Capasso, Anna, Nappi, Anna, Martini, Giulia, Napolitano, Stefania, Rachiglio, Anna Maria, Normanno, Nicola, Cappabianca, Salvatore, Reginelli, Alfonso, Bisceglie, Maurizio Di, Latiano, Tiziana Pia, Maiello, Evaristo, Orditura, Michele, Vita, Fernando De, Morgillo, Floriana, Ciardiello, Fortunato, Troiani, Teresa
Format: Artigo
Langue:Inglês
Publié: ESMO Open 2017
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5703385/
https://ncbi.nlm.nih.gov/pubmed/29211816
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2017-000177
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires